Super Religare Laboratories Ltd (SRL), a subsidiary of Fortis Healthcare Ltd, is looking to file its draft red herring prospectus (DRHP) with the securities market regulator SEBI to float a public ...
TO READ THE FULL STORY
- The only platform exclusively covering Private Investments in India.
Exclusive reporting, expert analyses and commentary on PE/VC/M&A deals and dealmakers
Daily, weekly and monthly curated newsletters on the alternative investment ecosystem in India
Participation in VCCircle Marquee events at concessional rates
Latest VCCEdge annual, quarterly and industry reports
Comprehensive | Accurate | Unbiased | Impeccably sourced